FERRI, Clodoveo
 Distribuzione geografica
Continente #
NA - Nord America 45.177
EU - Europa 24.743
AS - Asia 15.569
SA - Sud America 1.882
AF - Africa 178
Continente sconosciuto - Info sul continente non disponibili 38
OC - Oceania 38
Totale 87.625
Nazione #
US - Stati Uniti d'America 44.795
GB - Regno Unito 9.840
IT - Italia 6.481
CN - Cina 5.444
SG - Singapore 4.147
HK - Hong Kong 2.706
SE - Svezia 1.964
BR - Brasile 1.590
DE - Germania 1.431
UA - Ucraina 1.374
TR - Turchia 1.313
RU - Federazione Russa 804
FR - Francia 768
FI - Finlandia 762
BG - Bulgaria 494
KR - Corea 464
VN - Vietnam 401
IN - India 326
ID - Indonesia 216
IE - Irlanda 195
NL - Olanda 183
CA - Canada 175
JP - Giappone 135
AR - Argentina 109
MX - Messico 105
ZA - Sudafrica 78
PL - Polonia 74
BZ - Belize 65
IR - Iran 62
ES - Italia 60
BE - Belgio 57
BD - Bangladesh 53
MY - Malesia 51
EC - Ecuador 50
AT - Austria 40
RO - Romania 38
LT - Lituania 35
EU - Europa 34
IQ - Iraq 34
AU - Australia 30
CL - Cile 30
AE - Emirati Arabi Uniti 27
CO - Colombia 26
UZ - Uzbekistan 26
CH - Svizzera 25
PK - Pakistan 24
PY - Paraguay 24
MA - Marocco 23
SA - Arabia Saudita 23
EG - Egitto 17
TW - Taiwan 17
VE - Venezuela 17
CZ - Repubblica Ceca 15
IL - Israele 15
PE - Perù 15
PT - Portogallo 14
TN - Tunisia 14
NP - Nepal 13
TH - Thailandia 13
KE - Kenya 12
KG - Kirghizistan 11
LV - Lettonia 11
AZ - Azerbaigian 10
BO - Bolivia 10
HU - Ungheria 10
NO - Norvegia 10
UY - Uruguay 10
GR - Grecia 9
LU - Lussemburgo 8
DO - Repubblica Dominicana 7
JO - Giordania 7
PH - Filippine 7
BY - Bielorussia 6
NZ - Nuova Zelanda 6
OM - Oman 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
KZ - Kazakistan 5
MD - Moldavia 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
CI - Costa d'Avorio 4
JM - Giamaica 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
MK - Macedonia 3
RS - Serbia 3
SN - Senegal 3
AM - Armenia 2
BW - Botswana 2
CY - Cipro 2
EE - Estonia 2
GH - Ghana 2
ML - Mali 2
NG - Nigeria 2
Totale 87.583
Città #
Southend 7.706
Fairfield 4.988
Santa Clara 3.969
Woodbridge 3.471
Ashburn 2.794
Jacksonville 2.746
Hong Kong 2.698
Houston 2.636
Singapore 2.574
Chandler 2.064
Hefei 1.952
Ann Arbor 1.929
Seattle 1.788
Wilmington 1.725
Dearborn 1.674
Cambridge 1.600
London 1.147
Nyköping 1.083
Los Angeles 917
Chicago 905
Beijing 884
Izmir 823
Modena 614
San Diego 524
Princeton 522
Sofia 489
Milan 476
Eugene 447
Seoul 419
Rome 416
New York 369
Salt Lake City 360
Helsinki 319
Buffalo 269
Council Bluffs 261
Des Moines 246
Moscow 243
Columbus 239
Shanghai 213
Dallas 203
The Dalles 200
Tampa 189
Jakarta 188
Redwood City 179
Atlanta 176
Elk Grove Village 171
Bremen 169
Dublin 167
São Paulo 137
San Jose 127
Ho Chi Minh City 124
Bologna 121
Norwalk 110
Florence 109
Boardman 107
Guangzhou 102
Naples 94
Falls Church 93
Palermo 92
Hanoi 90
Sterling 90
Delhi 82
Lancaster 81
Turin 81
Frankfurt am Main 76
Tokyo 76
Phoenix 72
Munich 70
Genoa 68
Nanjing 68
New Delhi 68
Verona 67
Bari 66
Belize City 65
Catania 60
Dong Ket 56
Miami 54
Jinan 52
Kunming 51
Padova 51
Warsaw 51
Brussels 50
Detroit 50
Dulles 50
Toronto 50
Redondo Beach 48
Montreal 46
Belo Horizonte 44
Hounslow 44
Denver 43
Kansas City 41
Mexico City 41
Cagliari 40
Brooklyn 39
Johannesburg 39
San Francisco 39
San Mateo 37
Zhengzhou 36
Indiana 35
Rio de Janeiro 35
Totale 63.659
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.670
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 846
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 735
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 714
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 496
Semeiotica dell'articolazione temporo-mandibolare 480
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 376
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 337
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 333
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 332
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 330
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 323
B-cells and mixed cryoglobulinemia 322
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 301
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 301
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 296
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 295
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 292
Current treatment of hepatitis C-associated rheumatic diseases. 290
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 286
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 285
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 281
Aortic pulse wave velocity measurement in systemic sclerosis patients. 278
Validation of the classification criteria for cryoglobulinaemic vasculitis 277
Elevated Troponin Serum Levels in Adult Onset Still's Disease 277
Cardiac Involvement in Systemic Vasculitis 276
Heart involvement and systemic sclerosis 274
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 274
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 273
Endocrine manifestations of hepatitis C virus infection. 273
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 273
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 272
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 271
Thymus alterations and systemic sclerosis 271
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 270
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 269
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 269
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 267
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 267
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 265
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 264
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 264
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 262
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 262
GISEA: an Italian biological agents registry in rheumatology 261
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 260
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 259
Scleroderma digital ulcers complicated by infection with fecal pathogens. 259
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 257
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 256
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 256
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 254
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 253
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 253
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 253
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 252
Systemic sclerosis in childhood - Clinical and immunologic features of 153 patients in an international database 251
Cytokines and HCV-related disorders 251
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 248
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 248
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 247
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 247
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 246
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 246
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 245
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 244
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 244
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 243
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 242
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 242
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 241
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 237
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 236
L-Arginine in pregnant scleroderma patients 236
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 235
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 235
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 235
Cardiovascular risk and prostanoids in systemic sclerosis 233
Amlodipine in the treatment of Raynaud's phenomenon 233
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. 232
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: The glucocorticoid induced OsTeoporosis TOol (GIOTTO) study 229
Associations between Systemic Sclerosis and Thyroid Diseases 229
New targeted molecular therapies for dedifferentiated thyroid cancer 229
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 229
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 228
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 228
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 226
HCV and cryoglobulinemic vasculitis. 225
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 225
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 225
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 225
HCV-related rheumatic manifestations and therapeutic strategies 225
The A, B, Cs of viral hepatitis in the biologic era. 224
Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change 223
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes] 223
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 223
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 223
Non HCV-related mixed cryoglobulinemia 222
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 221
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 221
Totale 31.242
Categoria #
all - tutte 380.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 380.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.312 0 0 0 0 1.067 937 958 1.698 404 1.068 657 523
2021/20227.888 212 961 810 688 225 438 425 429 890 607 1.236 967
2022/20237.687 999 615 410 558 961 1.173 370 689 962 183 469 298
2023/20246.186 242 363 373 611 1.305 500 593 655 145 383 413 603
2024/202516.462 663 224 296 1.313 3.090 2.335 829 929 1.880 1.373 1.658 1.872
2025/202611.711 1.671 1.206 2.548 4.693 1.593 0 0 0 0 0 0 0
Totale 88.367